$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

GERD Symptoms in the General Population: Prevalence and Severity Versus Care-Seeking Patients 원문보기

Digestive diseases and sciences, v.59 no.10, 2014년, pp.2488 - 2496  

Cohen, Erica ,  Bolus, Roger ,  Khanna, Dinesh ,  Hays, Ron D. ,  Chang, Lin ,  Melmed, Gil Y. ,  Khanna, Puja ,  Spiegel, Brennan

Abstract AI-Helper 아이콘AI-Helper

Prior estimates suggest that up to 40% of the US general population (GP) report symptoms of gastroesophageal reflux disease (GERD). However, symptoms in the GP versus patients seeking care for gastrointestinal (GI) complaints have not been compared. We estimated the prevalence and severity of GERD s...

참고문헌 (33)

  1. Aliment Pharmacol Ther J Tack 35 1257 2012 10.1111/j.1365-2036.2012.05086.x Tack J, Becher A, Mulligan C, et al. Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life. Aliment Pharmacol Ther. 2012;35:1257-1266. 

  2. Aliment Pharmacol Ther A Becher 34 618 2011 10.1111/j.1365-2036.2011.04774.x Becher A, El-Serag H. Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34:618-627. 

  3. Clin Gastroenterol Hepatol HB El-Serag 5 17 2007 10.1016/j.cgh.2006.09.016 El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007;5:17-26. 

  4. A Gallup survey on heartburn across America. Princeton, NJ: The Gallup Organization, Inc., 1988. 

  5. Am J Gastroenterol L Agreus 96 2905 2001 10.1016/S0002-9270(01)03242-7 Agreus L, Svardsudd K, Talley NJ, et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001;96:2905-2914. 

  6. Can J Gastroenterol RN Fedorak 24 431 2010 10.1155/2010/296584 Fedorak RN, Veldhuyzen van Zanten S, Bridges R. Canadian Digestive Health Foundation public impact series: gastroesophageal reflux disease in Canada: incidence, prevalence, and direct and indirect economic impact. Can J Gastroenterol. 2010;24:431-434. 

  7. Dig Dis Sci L Frank 45 809 2000 10.1023/A:1005468332122 Frank L, Kleinman L, Ganoczy D, et al. Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life. Dig Dis Sci. 2000;45:809-818. 

  8. Gut J Dent 54 710 2005 10.1136/gut.2004.051821 Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710-717. 

  9. Gastroenterology AF Peery 143 1179e1-3 2012 10.1053/j.gastro.2012.08.002 Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143:1179e1-3-1187e1-3. 

  10. Clin Gastroenterol Hepatol M Camilleri 3 543 2005 10.1016/S1542-3565(05)00153-9 Camilleri M, Dubois D, Coulie B, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005;3:543-552. 

  11. Gastroenterology GR Locke 3rd 112 1448 1997 10.1016/S0016-5085(97)70025-8 Locke GR 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448-1456. 

  12. Aliment Pharmacol Ther H El-Serag 29 470 2009 10.1111/j.1365-2036.2008.03901.x El-Serag H, Hill C, Jones R. Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database. Aliment Pharmacol Ther. 2009;29:470-480. 

  13. Aliment Pharmacol Ther JF Bretagne 23 607 2006 10.1111/j.1365-2036.2006.02811.x Bretagne JF, Honnorat C, Richard-Molard B, et al. Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms. Aliment Pharmacol Ther. 2006;23:607-616. 

  14. Eur J Med Res M Solmaz 8 549 2003 Solmaz M, Kavuk I, Sayar K. Psychological factors in the irritable bowel syndrome. Eur J Med Res. 2003;8:549-556. 

  15. Nat Rev Gastroenterol Hepatol L Oudenhove Van 10 158 2013 10.1038/nrgastro.2013.10 Van Oudenhove L, Aziz Q. The role of psychosocial factors and psychiatric disorders in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013;10:158-167. 

  16. Med Care D Cella 45 S3 2007 10.1097/01.mlr.0000258615.42478.55 Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007;45:S3-S11. 

  17. J Neurogastroenterol Motil BM Spiegel 19 137 2013 10.5056/jnm.2013.19.2.137 Spiegel BM. Patient-reported outcomes in gastroenterology: clinical and research applications. J Neurogastroenterol Motil. 2013;19:137-148. 

  18. 10.1038/ajg.2014.237 Spiegel B, Hays RD, Bolus R, et al. Development of the NIH Patient Reported Outcomes Measurement Information System (PROMIS®) Gastrointestinal Symptom Scales. Am J Gastroenterol. 2014 (in press). 

  19. Aliment Pharmacol Ther JS Labus 20 89 2004 10.1111/j.1365-2036.2004.02007.x Labus JS, Bolus R, Chang L, et al. The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther. 2004;20:89-97. 

  20. Psychosom Med JS Labus 69 89 2007 10.1097/PSY.0b013e31802e2f24 Labus JS, Mayer EA, Chang L, et al. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index. Psychosom Med. 2007;69:89-98. 

  21. Qual Life Res DA Revicki 7 75 1998 10.1023/A:1008841022998 Revicki DA, Wood M, Wiklund I, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998;7:75-83. 

  22. Med Care DA DeWalt 45 S12 2007 10.1097/01.mlr.0000254567.79743.e2 DeWalt DA, Rothrock N, Yount S, et al. Evaluation of item candidates: the PROMIS qualitative item review. Med Care. 2007;45:S12-S21. 

  23. 10.1038/ajg.2010.383 Spiegel B, Khanna D, Bolus R, et al. Understanding gastrointestinal distress: a framework for clinical practice. Am J Gastroenterol. 2011;106:380-385. 

  24. Am J Gastroenterol LH Baker 90 1797 1995 Baker LH, Lieberman D, Oehlke M. Psychological distress in patients with gastroesophageal reflux disease. Am J Gastroenterol. 1995;90:1797-1803. 

  25. Clin Gastroenterol Hepatol RK Wong 11 151 2013 10.1016/j.cgh.2012.07.019 Wong RK, Drossman DA, Weinland SR, et al. Partner burden in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013;11:151-155. 

  26. Clin Gastroenterol Hepatol BM Spiegel 11 156 2013 10.1016/j.cgh.2012.10.023 Spiegel BM. Burden of illness in irritable bowel syndrome: looking beyond the patient. Clin Gastroenterol Hepatol. 2013;11:156-157. 

  27. Psychosom Med BD Naliboff 66 426 2004 10.1097/01.psy.0000124756.37520.84 Naliboff BD, Mayer M, Fass R, et al. The effect of life stress on symptoms of heartburn. Psychosom Med. 2004;66:426-434. 

  28. Aliment Pharmacol Ther B Delaney 20 2 2004 10.1111/j.1365-2036.2004.02219.x Delaney B. Prevalence and epidemiology of gastro-esophageal reflux disease. Aliment Pharmacol Ther. 2004;20:2-4. 

  29. Gastroenterology NJ Talley 102 1259 1992 10.1016/0016-5085(92)90764-P Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992;102:1259-1268. 

  30. Gastroenterology HB El-Serag 126 1692 2004 10.1053/j.gastro.2004.03.077 El-Serag HB, Petersen NJ, Carter J, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004;126:1692-1699. 

  31. J Natl Cancer Inst H Pohl 97 142 2005 10.1093/jnci/dji024 Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142-146. 

  32. Gut EM Soest van 54 1062 2005 10.1136/gut.2004.063685 van Soest EM, Dieleman JP, Siersema PD, et al. Increasing incidence of Barrett’s oesophagus in the general population. Gut. 2005;54:1062-1066. 

  33. 10.1016/S0002-9343(99)00121-7 Locke GR, 3rd, Talley NJ, Fett SL, et al. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106:642-649. 

관련 콘텐츠

오픈액세스(OA) 유형

GREEN

저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로